Understanding Myelofibrosis Care Options if You’re Not a Transplant Candidate

Name: Understanding Myelofibrosis Care Options if You’re Not a Transplant Candidate
Start: 2025-09-23T13:00:00-04:00
End: 2025-09-23T14:00:00-04:00

Understanding Myelofibrosis Care Options if You’re Not a Transplant Candidate

Webinar

Sep 23, 2025 / 01:00PM - 02:00PM EDT

videocam

Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Join the HealthTree Foundation to learn what can be done for individuals with myelofibrosis who are not eligible for a stem cell transplant. This is a great opportunity to learn from and ask questions to an MPN expert.

Schedule & Agenda

1:00 PM

Introductions

Dalton Bean

Dalton introduces the agenda of the event and our featured speaker Dr. Lindsay Rein

1:00 PM

Introductions

Dalton Bean

Dalton introduces the agenda of the event and our featured speaker Dr. Lindsay Rein

1:05 PM

Presentation

Lindsay Rein, MD

Dr. Rein talks about treatment options when not elegible for transplant

1:05 PM

Presentation

Lindsay Rein, MD

Dr. Rein talks about treatment options when not elegible for transplant

1:35 PM

Questions and Answers

Audience

Type your questions in the chat and we will answer them!

1:35 PM

Questions and Answers

Audience

Type your questions in the chat and we will answer them!

Speakers & Moderators

Dalton Bean

Lehi, UT

Dalton joined HealthTree in 2024 as the CLL and MF Education Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Read Bio

Lindsay Rein, MD

Durham, NC

Dr. Lindsay Rein is an Associate Professor of Medicine in the Division of Hematologic Malignancies and Cellular Therapy at Duke University where she sees and treats patients with various myeloproliferative neoplasms (MPNs). Dr. Rein leads a program of both early and late phase clinical trials for patients with MPNs and also led the recent establishment of a mastocytosis center of excellence at Duke for patients with systemic mastocytosis and associated mast cell disorders. She is a panel member for the NCCN guidelines for MPNs, systemic mastocytosis, and CML and is also a member of the H Jean Khoury Cure CML Consortium.

Read Bio

Join the Conversation

This event is part of the Treatments & Drugs group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.